MadeAi releases AI-driven software for pharmaceutical dossier development
Cambridge-based MadeAi has launched Dossier Expert, a software platform designed to accelerate the creation and maintenance of pharmaceutical value dossiers.
MadeAi has released a new software tool, Dossier Expert, aimed at automating the development of formularies and value dossiers for the pharmaceutical industry. The platform utilizes agentic AI to synthesize evidence and manage updates, with the company claiming it reduces drafting and revision time by up to 70 percent.
Traditional dossier production often involves labor-intensive data extraction and cross-departmental coordination. Dossier Expert introduces source-level traceability, intended to provide transparency and simplify the auditing process for regulatory submissions.
As the pharmaceutical sector faces increasing pressure to shorten timelines for drug approvals and market access, technology providers are shifting toward automated evidence synthesis. MadeAi’s entry into this segment reflects a broader trend of integrating specialized AI agents into document-heavy regulatory workflows. The platform is currently available for pharmaceutical manufacturers seeking to manage complex evidence libraries.